Prokineticin-1/endocrine gland-derived vascular endothelial growth factor is a survival factor for human multiple myeloma cells

References

• Alsayed Y, Ngo H, Runnels J, et al Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 2007;109:2708–2717.
   PubMed Web of Science ®Google Scholar
• Monnier J, Samson M. Cytokine properties of prokineticins. FEBS J 2008;275:4014–4021.
   PubMed Web of Science ®Google Scholar
• Cole LW, Sidis Y, Zhang C, et al Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab 2008;93:3551–3559.
   PubMed Web of Science ®Google Scholar
• LeCouter J, Lin R, Tejada M, et al The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA 2003;100:2685–2690.
   PubMed Web of Science ®Google Scholar
• LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci USA 2004;101:16813–16818.
   PubMedGoogle Scholar
• Negri L, Lattanzi R, Giannini E, Melchiorri P. Bv8/prokineticin proteins and their receptors. Life Sci 2007;81:1103–1116.
   PubMed Web of Science ®Google Scholar
• Maldonado-Perez D, Evans J, Denison F, Millar RP, Jabbour HN. Potential roles of the prokineticins in reproduction. Trends Endocrinol Metab 2007;18:66–72.
   PubMed Web of Science ®Google Scholar
• Hu WP, Zhang C, Li JD, et al Impaired pain sensation in mice lacking prokineticin 2. Mol Pain 2006;2:35.
   PubMed Web of Science ®Google Scholar
• Li JD, Hu WP, Boehmer L, et al Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J Neurosci 2006;26:11615–11623.
   PubMed Web of Science ®Google Scholar
• Shojaei F, Wu X, Zhong C, et al Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007;450:825–831.
   PubMed Web of Science ®Google Scholar
• Fry M, Cottrell GT, Ferguson AV. Prokineticin 2 influences subfornical organ neurons through regulation of MAP kinase and the modulation of sodium channels. Am J Physiol Regul Integr Comp Physiol 2008;295:R848–R856.
   Google Scholar
• Li QF, Huang WR, Duan HF, Wang H, Wu CT, Wang LS. Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells. Oncogene 2007;26:7904–7908.
   PubMed Web of Science ®Google Scholar
• Li QF, Wu CT, Duan HF, et al Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis. Br J Haematol 2007;138:632–639.
   PubMed Web of Science ®Google Scholar
• Oehen S, Brduscha-Riem K. Naive cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: a pitfall for T cell memory studies? Eur J Immunol 1999;29:608–614.
   PubMed Web of Science ®Google Scholar
• Oostendorp RA, Audet J, Eaves CJ. High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. Blood 2000;95:855–862.
   PubMed Web of Science ®Google Scholar
• Ngan ES, Tam PK. Prokineticin-signaling pathway. Int J Biochem Cell Biol 2008;40:1679–1684.
   PubMed Web of Science ®Google Scholar
• Perdiguero E, Ruiz-Bonilla V, Gresh L, et al Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J 2007;26:1245–1256.
   PubMed Web of Science ®Google Scholar
• Fields TA, Casey PJ. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 1997;321(Pt 3):561–571.
   PubMed Web of Science ®Google Scholar
• Zhou P, Qian L, Kozopas KM, Craig RW. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 1997;89:630–643.
   PubMed Web of Science ®Google Scholar
• Opferman JT, Latai A, Benad C, Sorcinelli MD, Ong CC, Korsmeyer SJ. Development and maintenance of B and T lymphocytes requires antiapoptotic MCH. Nature 2003;426:671–676.
   PubMed Web of Science ®Google Scholar
• Le Gouill S, Podar K, Amiot M, et al VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis. Blood 2004;104:2886–2892.
   PubMed Web of Science ®Google Scholar
• Fleischer B, Schulze-Bergkamen H, Schuchmann M, et al Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. Int J Oncol 2006;28:25–32.
   PubMed Web of Science ®Google Scholar
• Kuo ML, Chuang SE, Lin MT, Yang SY. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene 2001;20:677–685.
   PubMed Web of Science ®Google Scholar
• Pitteloud N, Zhang C, Pignatelli D, et al Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 2007;104:17447–17452.
   PubMed Web of Science ®Google Scholar
• Zhou QY, Cheng MY. Prokineticin 2 and circadian clock output. FEBS J 2005;272:5703–5709.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang N, Conejo-Garcia JR, et al Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. Clin Cancer Res 2003;9:264–272.
   PubMed Web of Science ®Google Scholar
• Goi T, Fujioka M, Satoh Y, et al Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res 2004;64:1906–1910.
   PubMed Web of Science ®Google Scholar
• Hideshima T, Akiyama M, Hayashi T, et al Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu. Blood 2003;101:703–705.
   PubMed Web of Science ®Google Scholar
• Lentzsch S, Chatterjee M, Gries M, et al PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. Leukemia 2004;18:1883–1890.
   PubMed Web of Science ®Google Scholar
• Yoon CM, Hong BS, Moon HG, et al Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2 + signaling pathways. Blood 2008;112:1129–1138.
   PubMed Web of Science ®Google Scholar
• Puthier D, Bataille R, Amiot M. IL-6 up-regulates mcl-1 in human myeloma cells through JAK/STAT rather than ras/MAP kinase pathway. Eur J Immunol 1999;29:3945–3950.
   PubMed Web of Science ®Google Scholar